AARDEX Group

AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials

Liege, Belgium- February 2, 2023: Adherence specialists AARDEX Group and remote research platform experts in the Clinpal team at Cambridge Cognition have teamed up to provide next-level adherence monitoring during hybrid and decentralized clinical trials (DCTs). Integrating AARDEX Groupís MEMS dosing capture and analytics system with Cambridge Cognitionís Clinpal DCT platform, including a video consultation,...

medmix Drug Delivery (Haselmeier™) and AARDEX Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials.

Liege, Belgium - November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier¥s D-Flex™ Logbook with AARDEX Groupís Medication Adherence software and hardware ecosystem. Clinical testing during new drug development is costly and time intensive for pharmaceutical and biotech companies. The need for solutions, helping them to shorten testing...
TheLabs - Liege Science Park, 15/1, rue bois St Jean, 4102 Seraing Belgium

+32 4 374 86 30